-
, including metabolomics, proteomics, and transcriptomics and use them to identify systems-level mechanisms in cancer to enhance treatment efficacy by uncovering new drug targets, biomarkers, and resistance
-
transcriptomics and use them to identify systems-level mechanisms in cancer to enhance treatment efficacy by uncovering new drug targets, biomarkers, and resistance mechanisms. We are specifically interested in
-
, emphasizing the integration of basic neuroscience research with clinical, health economics and outcomes research. Rapid progress in this area of research has led to the discovery of new methods for early
-
: Advanced cell culture, drug testing and immunofluoresence Molecular biology techniques including PCR and Western blot Imaging techniques and data analysis Metabolic profiling assays Sample preparation